Reducing Radiation Dermatitis for PBS Proton Therapy Breast Cancer Patients Using SpotDelete.
05/11/2024
/
Publications
/
Pencil Beam Scanning - PBS
This study investigated a technique of eliminating proton spots (SpotDelete) in the 0.5 cm skin rind when using PBS PT for breast cancer. In the SpotDelete...
Quantification of Acute Skin Toxicities in Patients with Breast Cancer Undergoing Adjuvant Proton vs Photon Radiation Therapy
02/04/2019
/
Publications
/
Pencil Beam Scanning - PBS
Published in the Red Journal, the study by University of Maryland examined the acute skin toxicity in the form of radiation dermatitis (RD) or skin...
Consensus guidelines for implementing PBS PT for thoracic malignancies
05/05/2017
/
Publications
/
Pencil Beam Scanning - PBS
A Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee...
Treating Hodgkin and non-Hodgkin lymphoma with proton therapy
22/12/2020
/
White Paper
/
Pencil Beam Scanning - PBS
VMAT
Proton therapy is different from photon-based radiotherapy. Because of their unique physical properties, protons have no ‘exit’ dose and very little ‘entrance’...
Breast and chest wall treatment with pencil beam scanning at the proton therapy center in Prague
02/02/2018
/
Event
/
Proton therapy center
Pencil Beam Scanning - PBS
The Proton Therapy Centre in Prague (PTC) is a leading global health care facility and one of the most advanced proton therapy providers in Europe. The centre...
Lung treatment with pencil beam scanner at the Texas Center of Proton Therapy
01/01/2017
/
Event
/
Pencil Beam Scanning - PBS
Proton therapy center
The Texas Center for Proton Therapy brings an advanced cancer treatment to North Texas that offers more hope to cancer patients. The 63,000-square-foot center...
Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis.
14/07/2021
/
Publications
/
IMRT
Pencil Beam Scanning - PBS
For a cohort of 219 patients with stage III NSCLC who received definitive concurrent chemoradiotherapy, 25 patients (11.4%) underwent PBSPT and 194 patients (88...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.